Results 181 to 190 of about 15,580 (252)

Novel nonsteroidal topical therapies for pediatric atopic dermatitis: a systematic review and network meta-analysis of randomized controlled trials. [PDF]

Front Immunol
Yang Y, Zhao D, Wang Y, Yang Q.
europepmc   +1 more source

Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series

Australasian Journal of Dermatology, Volume 67, Issue 7, Page 420-423, November 2026.
ABSTRACT We present three patients who developed allergic contact dermatitis (ACD) from benzalkonium chloride (BAK) in ophthalmic drops. BAK is a preservative commonly found in ophthalmic formulations and there is a rising trend of ACD to this allergen. The irritant and sensitising properties of BAK on the ocular mucosa will be discussed.
Arav Kannen, Penelope Harrison, Elizabeth Christou   +2 more
wiley   +1 more source

Dupilumab‐Associated Erythema Multiforme‐Like Eruption With Lichenoid Histology in a Paediatric Patient: A Case Report

Australasian Journal of Dermatology, Volume 67, Issue 7, Page 424-427, November 2026.
ABSTRACT Dupilumab‐associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab‐associated erythema multiforme‐like eruption in a 5‐year‐old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and
Paul Sun Woo Kim, Jacqueline Tu, Kelvin Truong, Gloria Fong, William Luu, Narinder Kaur, Miriam Fewtrell, Li‐Chuen Wong   +7 more
wiley   +1 more source

Association between severity of different body regions and inadequate control of atopic dermatitis: results from a cross-sectional and longitudinal study. [PDF]

Front Allergy
Li Z, Yu R, Lin Y.
europepmc   +1 more source

Research Priorities for Children With Food Allergy: A UK James Lind Alliance Priority Setting Partnership

Clinical &Experimental Allergy, Volume 56, Issue 11, Page 1401-1410, November 2026.
The UK childhood food allergy James Lind Alliance Priority Setting Partnership collaboratively identified the most important research priorities highlighting the breadth of research required to improve the prevention, diagnosis, treatment and broader impacts of food allergy on those directly impacted. These provide a clear, stakeholder‐driven agenda to
Roxanne M. Parslow, Farhad Shokraneh, Sara J. Brown, Mary Feeney, Graham Roberts, Hora Soltani, Joanne Walsh, Amy Dobson, Emma Vaughan, Deborah Marriage, Suzi Holland, Mary Kelly, Holly Shaw, Alicia Kennedy, Eden Byrne, Liliana Jackson, Gail Jackson, Lauren Gluyas, Jonathan Gower, Alyson Huntley, Matthew J. Ridd   +20 more
wiley   +1 more source

Unveiling How Floods Marginalize Women: Gendered Vulnerabilities and Capabilities in Pekalongan City, Indonesia

Gender, Work &Organization, Volume 33, Issue 6, Page 2503-2518, November 2026.
ABSTRACT This study examines how recurrent coastal flooding reshapes gendered vulnerabilities and capabilities in two communities in Pekalongan City, Indonesia. Drawing on in‐depth interviews, focus‐group discussions, and observations, the analysis applies an integrated framework of vulnerabilities and capabilities to investigate changes in livelihoods,
Isnan Fauzi, Sonia Roitman, Maria Ekacarini Jayanimitta   +2 more
wiley   +1 more source

Real-world Efficacy and Safety of Stapokibart in Children and Adolescents with Moderate-to-severe Atopic Dermatitis: A Retrospective Study. [PDF]

Acta Derm Venereol
Li L, Chen Y, Lin M, Hou L, Shao Y, Li Y, Shao J, Yu X, Chen T, Li Z.   +9 more
europepmc   +1 more source

Treatment‐associated phenotype switching between psoriasis and atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 11, Page 1831-1839, November 2026.
This international, multicentre real‐world study of 148 patients’ documents treatment‐associated, bidirectional phenotype switching between psoriasis and atopic dermatitis. Psoriasis‐to‐eczematous switches occurred predominantly with IL‐17 and IL‐23 inhibitors, whereas AD‐to‐psoriasiform switches occurred exclusively during treatment with biologic ...
Tiago Torres, Mario Valenti, Anna Balato, Matteo Megna, Paolo Gisondi, Vimal Prajapati, Stefano Piaserico, Julia‐Tatjana Maul, Lara Valeska Maul, Jose Manuel Carrascosa, Francisco José Navarro‐Triviño, Elizabeth Lazaridou, César Ferreira, Jacopo Tartaglia, Christian Ciolfi, Athina‐Ioanna Daponte, Eugenia Veronica Di Brizzi, Maddalena Napolitano, Barbara Leal Guerra, Monica Munera‐Campos, Siddhartha Sood, Silvia Ferruci, Francesca Prignano, Esteban Dauden, Mar Llamas‐Velasco, Ron Vender, Jensen Yeung, Angelo Marzano, Luis Puig   +28 more
wiley   +1 more source

Clinical Dose-Response of Inflammation Formula Number 1 Granules Versus Traditional Decoction in the Treatment of Patients With Mild to Moderate Atopic Dermatitis: Protocol for a Multicenter Randomized Controlled Trial. [PDF]

JMIR Res Protoc
Li D, Ma X, Xu C, Li X, Meng Y, Jiang W, Luo G, Liu Y, Shen F, Gao X, Wang R, Li B.   +11 more
europepmc   +1 more source

Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 11, Page 1819-1830, November 2026.
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern, Simon Francis Thomsen, Georgios Kokolakis, Maurizio Podda, Gregor B. E. Jemec, Kurt Gebauer, Claus Zachariae, John Frew, Pablo Fernandez‐Peñas, Falk G. Bechara, Stefan Beissert, Sourabh Malandkar, Karen Scalzo‐Inguanti, Partha Nandy, Selvakumar Sukumar   +14 more
wiley   +1 more source